The true merits of liver allocation according to MELD scores: Survival after transplantation tells only one side of the story

Transplant International

Volumn 24, Issue 2, 2011, Pages 132-133

  Metselaar, Herold J ^a   Lerut, Jan ^b   Kazemier, Geert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HOSPITALIZATION COST; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MORTALITY; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

END STAGE LIVER DISEASE; HEALTH CARE RATIONING; HUMANS; LIVER TRANSPLANTATION; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; WAITING LISTS;

EID: 78651082555     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01177.x     Document Type: Note

References (10)

1. Weismuller T, Fikatas P, Schmidt J, et al. Multicenter evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany-limitations of the 'sickest first' concept. Transpl Int 2011; 24: 91.
2. Malinchoc M, Kamath P, Gordon F, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
3. Freeman R, Wiesner R, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7.
4. Kim W, Biggins S, Kremers W, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. New Engl J Med 2008; 359: 1018.
5. Desai N, Mange K, Crawford M, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99.
6. Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117.
7. Oberkofler C, Dutkowski P, Stocker R, et al. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care 2010; 14: R117.
8. Foxton M, Al-Freah M, Portal A, et al. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl 2010; 16: 668.
9. Axelrod D, Koffron A, Baker T, et al. The economic impact of ME:LD in liver transplant centers. Am J Transpl 2005; 5: 2297.
10. Schaubel D, Guidinger M, Biggins S, et al. Survival benefit-based deceased-donor liver allocation. Am J Transpl 2009; 9: 970.